While there is evidence in the literature that HBOT improves fasting glycaemia, declining it by 36% (16), and diminishing insulin resistance in diabetic patients, the mechanisms that account for the insulin-sensitizing effect of hyperbaric oxygenation still lack clarification. This evidence concerns the gene INS and Insulin resistance.